跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZYGABALIN HARD CAPSULE 150MG - HSA Drug Approval Details
Approvals
/
HSA
/
ZYGABALIN HARD CAPSULE 150MG
Approved
THERAPEUTIC
ZYGABALIN HARD CAPSULE 150MG
Changzhou Pharmaceutical Factory (CHINA)
🇸🇬 Health Sciences Authority
Approval Date
Jan 22, 2026
Approval ID
afc1c9d8285e8d2e
Company
Changzhou Pharmaceutical Factory (CHINA)
Type
Therapeutic
Approval Details
Approval Id
afc1c9d8285e8d2e
Drug Name
ZYGABALIN HARD CAPSULE 150MG
Product Name
ZYGABALIN HARD CAPSULE 150MG
Approval Number
SIN17442P
Approval Date
2026-01-22
Registrant
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
CAPSULE
Route Of Administration
ORAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 22, 2026
Approval ID
afc1c9d8285e8d2e
Type
Therapeutic
Back to HSA Approvals